Industry reports
Editor highlights

Search inside this page

Publishers

  • All
    • GBI Research

data types

Free Market Research Guides to Download

Drug Discovery and Development Analysis & Statistics, April 2014

You might be interested in: clinical trial, drug discovery, drug development, more »

» Purchase Premium Reports

1-30 of 41 reports
Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth

Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth

  • $ 3 500
  • Industry report
  • June 2013
  • by GBI Research

Summary GBI Research, a leading business intelligence provider, has released its latest research report ?Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products ...

  • Industries : Drug Discovery and Development
  • Countries : World
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes

Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes

  • $ 3 500
  • Industry report
  • November 2012
  • by GBI Research

Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes Summary GBI Research's new report, ?Biomarkers in Drug Discovery - Integration ...

  • Industries : Drug Discovery and Development
  • Countries : World
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation

Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation

  • $ 3 500
  • Industry report
  • November 2012
  • by GBI Research

Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation Summary GBI Research, a leading ...

  • Industries : Drug Discovery and Development
  • Countries : Asia
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity

Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market

Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market Summary GBI Research's new report, ?Accelerating Drugs to Market - Despite ...

  • Industries : Drug Discovery and Development
Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

  • $ 3 500
  • Industry report
  • August 2012
  • by GBI Research

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Summary GBI Research, leading business intelligence provider has released its latest research ...

  • Industries : Drug Discovery and Development
  • Countries : India, China, World
e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

  • $ 3 500
  • Industry report
  • July 2012
  • by GBI Research

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies Summary GBI Research, ...

  • Industries : Drug Discovery and Development
  • Countries : World
Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development

Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development

  • $ 3 500
  • Industry report
  • July 2012
  • by GBI Research

Summary GBI Research, leading business intelligence provider, has released its latest research report, entitled ?Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development". Ove ...

  • Industries : Drug Discovery and Development
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles

Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles Summary GBI Research in its report ?Endpoints - ...

  • Industries : Drug Discovery and Development
  • Countries : World
Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue

Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue Summary GBI Research's new report, ?Emerging Pharmaceutical ...

  • Industries : Drug Discovery and Development
  • Countries : Argentina
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward

Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

  • $ 3 500
  • Industry report
  • May 2012
  • by GBI Research

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

  • $ 3 500
  • Industry report
  • April 2012
  • by GBI Research

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs Summary GBI Research, the leading business ...

  • Industries : Drug Discovery and Development
  • Countries : World, India
Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success

Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success

  • $ 3 500
  • Industry report
  • January 2012
  • by GBI Research

Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success Summary GBI Research, the leading business intelligence ...

  • Industries : Drug Discovery and Development
  • Countries : World
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials

Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials

  • $ 3 500
  • Industry report
  • January 2012
  • by GBI Research

Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Drug Discovery and Development
  • Countries : World
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US

Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Emerging ...

  • Industries : Drug Discovery and Development
  • Countries : Poland
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted

Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted

  • $ 3 500
  • Industry report
  • November 2011
  • by GBI Research

Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : World
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly

Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly

  • $ 3 500
  • Industry report
  • October 2011
  • by GBI Research

Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
  • Countries : World
Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance Summary GBI Research has released its latest report, ?Post Marketing Clinical ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Japan, Europe, World
Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism

Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Drug Discovery and Development
  • Countries : Brazil, India, China, World
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets Summary GBI ...

  • Industries : Drug Discovery and Development
  • Countries : India, China
Pharmaceutical Partnership Deal Terminations

Pharmaceutical Partnership Deal Terminations

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Pharmaceutical Partnership Deal Terminations Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Pharmaceutical Partnership Deal Terminations? which provides ...

  • Industries : Drug Discovery and Development
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force

Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force

  • $ 3 500
  • Industry report
  • August 2011
  • by GBI Research

Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force Summary GBI Research's report, ?Emerging Pharmaceutical ...

  • Industries : Drug Discovery and Development
  • Countries : India
Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure

Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure

  • $ 3 500
  • Industry report
  • July 2011
  • by GBI Research

Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure Summary GBI Research, leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

  • $ 3 500
  • Industry report
  • July 2011
  • by GBI Research

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market Summary GBI Research, the leading business ...

  • Industries : Drug Discovery and Development
  • Countries : Brazil
Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

  • $ 3 500
  • Industry report
  • July 2011
  • by GBI Research

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player Summary GBI Research has released its latest ...

  • Industries : Drug Discovery and Development
  • Countries : Russian Federation
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development

Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development

  • $ 3 500
  • Industry report
  • July 2011
  • by GBI Research

Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development Summary GBI Research has released its latest report, ?Emerging ...

  • Industries : Drug Discovery and Development
  • Countries : Argentina
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs

Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs

  • $ 3 500
  • Industry report
  • June 2011
  • by GBI Research

Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs Summary GBI Research has released its latest report, ...

  • Industries : Drug Discovery and Development
Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

  • $ 3 500
  • Industry report
  • June 2011
  • by GBI Research

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management Summary GBI Research, the leading business intelligence provider, has ...

  • Industries : Drug Discovery and Development
  • Countries : India

» View Public Reports

About 3 200 reports

Global Clinical Trial : Innovation and Technology Trends

  • Industry report
  • April 2014
  • 16 pages

... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...


» Read our Company Profiles

1 Companies

GlaxoSmithKline P.L.C.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.